They both work in the same way to make you feel fuller for longer after meals
View Article This article is for informational purposes only and does not constitute medical advice
These include GLP1/glucagon dual agonists (AstraZeneca, Boehringer Ingelheim, Hanmi Pharma, Eli Lilly) , GIP/GLP1/glucagon tri-agonists (Hanmi Pharmaceuticals, Eli Lilly), or solo GIPR agonists (Eli Lilly, Zealand Pharma)
Cochrane Library [Internet]
At TrimRx, we recognize the importance of providing reliable information to our community, ensuring that everyone can make informed decisions about their health
Your insurance company may require prior authorization or step therapy (a trial of less expensive weight loss medications) before approving GLP-1 drugs